Navigation Links
Using Hormone Therapy to Shape Children’s Height to Social Norm

In the 1950s and 1960s, tall girls were coming up short in life. Viewed as unfeminine and less attractive to marriage suitors than shorter girls//, many otherwise healthy tall girls were given estrogen treatment to stunt their growth.

While estrogen therapy today for tall girls is rare, its use to conform a child’s height to fit social norms may provide valuable insight into the present-day use of growth hormone treatment for healthy boys of short stature.

In a historical review in the current issue of the Archives of Pediatric and Adolescent Medicine, lead author and University of Michigan Health System Pediatric Endocrinologist Joyce Lee, M.D, MPH, explores the use of estrogen treatment during the past 50 years to illustrate how scientific knowledge continues to be created and applied to fit within prevailing societal and political beliefs.

At its onset in the 1940s, estrogen therapy use to reduce height was limited to children at risk for tall stature due to acromegaly, a hormonal disorder that results when the pituitary gland produces excess growth hormone. Not too long after that, though, scientists began to wonder if the same therapy would prevent healthy, tall girls from becoming tall adults.

Why shouldn’t healthy tall girls be allowed to grow into tall adults? According to Lee, in the 1950s parents grew increasingly concerned with the social implications of their daughters being too tall, and worried they would have difficulty finding clothes that fit and even future employment as a flight attendant or ballet dancer.

The most commonly cited reason in scientific literature for reducing the height of tall girls, however, was social attractiveness.

“Since tall girls usually become tall women, the biggest concern seemed to be that tall women would have a hard time fitting in, being comfortable in social situations, and, most importantly, finding a man to marry,” says Lee, a member of the Chi ld Health Evaluation Research (CHEAR) Unit in the Division of General Pediatrics at U-M C.S. Mott Children’s Hospital.

Through the 1960s and 1970s, researchers began to take a closer look at the effects of estrogen therapy on a female’s growth, as well as her overall health. They noted positive effects of the therapy such as height reduction, and improvements in self-esteem and school performance. Treatment, however, had its downside. Many patients reported having nausea, headaches and weight gain, and there were more serious complications such as mild hypertension, benign breast disease and ovarian cysts.

Medical debate about its risk and effectiveness, combined with changing social culture in the 1970s and 1980s, slowed the use of estrogen therapy for tall girls. In a 1977 survey of the Lawson Wilkins Pediatric Endocrine Society, 50 percent of respondents treated tall girls with estrogen therapy. In 1999, a survey of the same endocrine society revealed that only 23 percent of the respondents treated tall girls in the past five years, and only 1 percent had treated more than five cases with estrogen therapy.

By 2003, growth hormone was approved by the U.S. Food and Drug Administration for treatment of short, but otherwise healthy children with idiopathic short stature. Although estrogen for tall stature and growth hormone for short stature are both used for altering height in children, Lee says there is one notable difference between the use of the two therapies: gender.

“While the treatment of tall stature with estrogen therapy was almost exclusively focused on girls, growth hormone treatment of healthy, short children occurs in twice as many boys as girls,” notes Lee. “Growth hormone treatment of short boys could be considered the 21st century counterpart to estrogen treatment of tall girls, as society still expects that tall women should not date or marry short men.”

Lee says estrogen treatment, too, ho lds important implication for future use and study of growth hormone therapy to modify children’s height. “We need to realize that scientific advances are always applied within a specific social context, and those societal norms and beliefs can greatly impact the work of practicing clinicians.”

SourceNewswise

'"/>




Related medicine news :

1. Preventing Strokes Using Less Invasive Techniques
2. Using Cholesterol Lowering Drugs Effectively
3. Using herbal remedies with chemotherapy may not be a good idea
4. Teenagers Using Hormones And Dietary Supplements To Good Physique
5. Using Stem Cells To Treat Incontinence In Women
6. Using Eyes As The Line Of Reference For Fetal Brain Imaging
7. Remote Robotic Surgery Using Miniature Robots
8. Driving While Using A Mobile Phone May Be Dangerous
9. Detecting Brain Abnormalities in Babies Using New Brain Scanners.
10. Mobilizing Stem Cells at the Injured Site Using Hyperbaric Oxygen Treatments.
11. Treatment of Sickle Cell Anemia Using Gene Therapy.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2017)... and MINNETONKA, Minn. (PRWEB) , ... March 29, ... ... development of medical office buildings (MOBs) and other outpatient facilities, and who are ... to look exclusively at those questions, Revista and Healthcare Real Estate Insights (HREI) ...
(Date:3/29/2017)... Norwalk, CT (PRWEB) , ... March 29, 2017 , ... ... Valuing —on Thursday, April 20, 2017, at 1:00 PM ET. A recording of the ... of the Interactive Webinar Series. , Home health and hospice companies are still popular ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... of Pittsburgh now have easier access to the robotic-assisted total-hip and partial-knee ... Network (AHN). Orthopaedic surgeons at Forbes Hospital and Jefferson Hospital recently started ...
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over 1.5 million SharePoint users ... for on-premises installation of its Help System for SharePoint was at the farm level. ... the entire tenant. , The company recently released a modified version of the ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s Chigurupati ... to directly address the resolution to globally reduce the harmful use of alcohol ... of FDA and TTB approved ingredients that when infused into alcohol, renders the ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... March 29, 2017 Varian Medical Systems (NYSE: ... for the second quarter of fiscal year 2017 following the ... news release will be followed by a teleconference available to ... and a link to the conference call webcast will be ... access the teleconference call and replay: ...
(Date:3/29/2017)... 2017  Spiral Therapeutics, Inc. today announced the ... S.L. for the worldwide exclusive rights to Bionure,s ... field of otolaryngology for aggregate payments of up ... agreement provides Spiral with the option to license ... profile. Under the terms of the agreement, Spiral ...
(Date:3/29/2017)... , March 29, 2017   Dynatronics Corporation ... the appointment of Cynthia L. McHenry ... be responsible for leading Dynatronics manufacturing, distribution, and ... report to Dynatronics, CEO Kelvyn H. Cullimore, ... an extensive search process conducted by the company ...
Breaking Medicine Technology: